Top Industry Leaders in the Antiemetics Market
Latest Antiemetics Companies Update:
Evoke Pharma's Exclusivity: In April 2022, Evoke Pharma received three-year exclusivity for Gimoti (metoclopramide) nasal spray, providing them a competitive edge in the oral alternative drug segment.
Acacia Pharmaceutical's FDA Approval: Barhemsys, Acacia Pharmaceutical's antiemetic, received US-FDA approval in February 2022, expanding their product portfolio and addressing a niche market for nausea and vomiting associated with migraine.
Pfizer's Transdermal Patch Development: In September 2023, Pfizer partnered with Relief Therapeutics to develop a transdermal patch for Aprepitant (Emend), aiming to improve patient compliance and ease of administration for chemotherapy-induced nausea and vomiting.
Meda Pharmaceuticals' Expansion: Meda Pharmaceuticals acquired Australian pharmaceutical company, Almirall, in January 2023, strengthening their market presence in antiemetics with Almirall's innovative NKTR-105.
List of Antiemetics Key companies in the market
- GSK (UK)
- Merck (US)
- Sanofi-Aventis (France)
- Pfizer Inc. (US)
- Mylan (US)
- Eli Lilly and Company (US)
- Johnson & Johnson (US)
- Baxter International (US)
- Reddy's Laboratories Inc. (India)